Physiological relevance of GPCR oligomerization and its impact on drug discovery
- 14 October 2008
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (23-24) , 1059-1066
- https://doi.org/10.1016/j.drudis.2008.09.002
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the κ-opioid receptorJournal of Neuroimmunology, 2008
- In Vivo Characterization of (−)(−)MCL-144 and (+)(−)MCL-193: Isomeric, Bivalent Ligands with Mu/Kappa Agonist PropertiesNeurochemical Research, 2008
- High-Throughput Screening Assay for the Identification of Compounds Regulating Self-Renewal and Differentiation in Human Embryonic Stem CellsCell Stem Cell, 2008
- Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addictionBritish Journal of Pharmacology, 2008
- How and why do GPCRs dimerize?Trends in Pharmacological Sciences, 2008
- Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptorEMBO Reports, 2008
- Identification of a serotonin/glutamate receptor complex implicated in psychosisNature, 2008
- GPCR monomers and oligomers: it takes all kindsTrends in Neurosciences, 2008
- Heterodimerization and surface localization of G protein coupled receptorsBiochemical Pharmacology, 2007
- Pharmacological chaperones: potential treatment for conformational diseasesTrends in Endocrinology & Metabolism, 2004